which reached NOK 1.94. A significant part of the organic growth came from volume mix, which contributed 2.7% this quarter. Most of the portfolio companies had positive volume growth, and the growth was particularly strong in Orkla Snack with a volume mix growth of 11.2%, primarily led by the confectionery category. Oklahoma Personal Care also had double-digit volume growth this quarter. Despite the challenging environment, Jotun continued to deliver underlying operating profit growth. I am pleased to see that eight of nine consolidated portfolio companies delivered underlying EBITDA-just improvements in the quarter. And in the overall picture, the volume mix was a key driver of EBIT-adjusted growth across the consolidated companies. Among those, Orca Snacks again stands out positively, with volume-driven underlying EBIT growth of 16%. The rolling 12-month EBIT margin improved slightly from the last quarter. Input price developments varied across the portfolio. Costs for marine products, meat and packaging increased versus last year. At the same time, costs for other input factors such as cocoa and dairy decreased. The outlook for prices remains fragmented across the different input factors. We expect prices to rise modestly in 2027. However, the outlook remains uncertain. As always, we continuously monitor the situation closely. This is our last quarterly presentation before our Captain Markets Day on December 1st. We are on track to finish 2026 within mid to upper range of our targets of 8-10% annual growth and underlying EBIT adjust. And the EBIT margin is also tracking within the target range. The return on capital employed has improved significantly over the strategy period, but we do not expect to reach 13%. With that, I hand it over to Arve.

Thank you Nils and good morning. So turning first to the income statement, I'll make some comments to some of the items. First of all operating revenues, reporting operating revenues declined Arve Regland Arve Regland This relates mainly to breakdowns of goodwill and trademarks in healthspan within Oykla Health and loss on sale of Ice Union in Oykla Food Ingredients. Under discontinued operations, we recorded a gain from reversal of provisions related to the sale of Sapa back in 2017. And as Nils mentioned, earnings per share adjusted increased by 4.9% this quarter. Cash flow from operations was 4.4 billion year to date, approximately 400 million lower than last year. And about half of the decline was due to working capital. And this reflects both a higher receivables following sales growth and a temporary inventory buildup ahead of an ERP implementation in Orkla Foods Norway. And cash flow before capital allocation was 3.9 billion year to date. So turning to capital allocation and leverage, so during the quarter share buybacks were approximately 1 billion and this includes both the completion of the 4 billion share buyback program announced in November last year as well as the new 4 billion share buyback program that we announced in September. Expansion investments increased with 260 million this quarter, mainly within Orkla snacks and Orkla food ingredients. The net cash flow effect from acquisitions and divestments during the quarter amounted to about 2.9 billion. And the largest element was the acquisition of the European Candy Group. And leverage was 2.1 times EBTA at the end of the quarter. So let's move to the portfolio companies with some more details and as usual we start with Jotun where the underlying revenue grew 13% in the third quarter across segments and markets driven by both volume and price. The gross margins declined because price increases did not fully offset the higher raw material costs. On an underlying basis, operating profit rose 1.3%. Reported operating profit fell 5.1%, reflecting negative currency translation effects. and Orkla's share of profit from Jotunn was down 6.6% to 563 million. Jotunn's outlook remains uncertain due to the conflict in the Middle East. Demand in war-affected markets has been resilient, but the conflict creates uncertainty around supply, logistics and business conditions. and Margin Pressure is expected to continue in the coming quarters. In Orkla Foods, organic revenue grew 2.4%, of which 1.5% came from volume mix. Growth platforms delivered volume mix growth of 5.3%, with growth in all markets. There was also a positive effect from the comparison to ERP challenges in the Czech Republic last year. Input costs increased slightly, with higher increases for mackerel and packaging. Underlying EBITDA just increased 7.6%, driven by revenue growth and continued cost discipline. Organic growth in all-class snacks was 5.6% and volume mix contributed a record high 11%. Organic growth was partly offset by lower prices mainly for chocolate products. The confectionery snacks and biscuit categories all delivered volume mix growth. Confectionery was the largest contributor with four main drivers. Bubs continued to grow in the US across the Nordics with further expansion in Finland and launches in Estonia and Latvia. Secondly, Smash also continued to grow including from its launch in Latvia. Thirdly, Chocolate Volumes continue to recover, supported by lower prices. And lastly, earlier Christmas sales than last year had an additional positive effect on volumes in the third quarter. Underlying EBITDA just increased by 16%, driven by higher volumes, but partly offset by higher advertising spend and SG&A costs. Organic growth in Åytala Home and Personal Care was 10%, almost entirely from volume mix. Volumes increased in Norway, Sweden and contract manufacturing, supported by more campaign activity. And part of the growth reflects positive-facing effects that shifted sales into the third quarter, partly from the second quarter, and partly from the fourth quarter. and underlying EBITDA just increased by 8.7%. Orkla food ingredients had a more muted development with organic revenue growth of 0.7%. Prices were lower, reflecting lower input costs in several markets and categories. Volume mix grew in bakery and sweet, But within plant-based, lower volumes and unfavorable mix effects contributed negatively to both overall volume mix and EBIT development. Underlying adjusted EBIT declined by 2%. Volume growth was more than offset by higher operating costs. And as we said last quarter, Orkla Food Ingredients is taking steps to reduce its cost base, however, with limited effect this year. Organic growth in Ortla Health was flat in the quarter. Price increases in most categories were offset by lower volume mix. Most of the decline came from food supplements, where price increases negatively impacted volumes. Oral health and functional personal care contributed positively to both revenue and EBIT growth. and the underlying EBITDA just increased 6.1%. Pricing and mix lifted the contribution margin, which more than offset higher operating costs. And as communicated earlier, we continue to expect weak profitability in the coming quarters in Orkla Health. And at the capital markets,